Patent ID: 11957746
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 16:
17. An immunogenic composition, comprising
a recombinant PCV2 ORF2 protein comprising a sequence having at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.5%, or 100% sequence identity with the sequence of SEQ ID NO:1 or SEQ ID NO:2, and
1.4-4.7 μM L-arginine or 4.0-12.2 μM L-lysine
and wherein the immunogenic composition is substantially free from a neutralized inactivating agent or substantially free from a neutralizing agent.